Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) [Phase 2]
Phase 2 study evaluating novel approaches to prevent graft-versus-host disease after allogeneic hematopoietic cell transplantation, with res…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Cytokine Induced Killer (CIK) Cells In Leukemia Patients [Phase 2]
A Phase 2 clinical trial evaluated Cytokine Induced Killer (CIK) cell therapy in leukemia; the study has completed and results were posted i…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Immunotherapy With CD19 CAR T-cells in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma [NA]
This update reports the completion of a clinical trial investigating CD19 CAR T-cell immunotherapy for relapsed or refractory CD19+ leukemia…
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies [Phase 1, Phase 2]
A multi-phase early-stage clinical trial evaluating CAR-T cell therapy for relapsed or refractory hematologic malignancies including leukemi…
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation with sirolimus and treated immune cells, for blood and lymph cancers, terminated wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection [Phase 4]
Phase 4 trial update on preemptive ethanol lock therapy in pediatric patients with leukemia/lymphoma undergoing treatment; study completed w…
-
CLINICAL_TRIALS trial_result · 2018-12-03Clinical Trial Update: CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy [Phase 1, Phase 2]
Preliminary update on CD19-directed CAR T cell therapy for relapsed/refractory B cell malignancies across Phase 1 and Phase 2 trials.
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: A Study in Participants With Acute Leukemia [Phase 2]
A Phase 2 clinical trial update for an acute leukemia study sponsored by Eli Lilly has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes [Phase 1, Phase 2]
Phase I/II study evaluating decitabine and valproic acid in relapsed/refractory leukemia or myelodysplastic syndromes; study completed.
-
CLINICAL_TRIALS trial_result · 2018-11-09Clinical Trial Update: Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia [Phase 1, Phase 2]
A clinical trial evaluating plitidepsin (Aplidin) in combination with cytarabine for relapsed/refractory leukemia was terminated; results we…
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant [NA]
Clinical trial update on GVHD prophylaxis with post-transplant cyclophosphamide in patients with renal insufficiency receiving matched relat…
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating Rituximab, Cyclophosphamide, and Pegfilgrastim in patients with leukemia or non-Hodgkin's lymphoma has c…
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies [Phase 2]
Phase 2 trial evaluating liposomal vincristine in pediatric and adolescent patients with relapsed malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia [Phase 1, Phase 2]
Clinical trial update on chemotherapy plus peripheral stem cell transplantation for leukemia conducted in Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating lenalidomide in combination with azacitidine for advanced myelodysplastic syndromes has completed with…
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia [Phase 2]
Phase 2 trial evaluating combination chemotherapy with rituximab for newly diagnosed Burkitt's lymphoma or leukemia has completed; results p…
-
CLINICAL_TRIALS trial_result · 2018-09-07Clinical Trial Update: HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCT [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating hypomethylating agents plus donor lymphocyte infusion versus donor lymphocyte infusion preemptive ther…
-
CLINICAL_TRIALS research · 2018-09-07Clinical Trial Update: WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation [Phase 2]
Phase 2 clinical trial investigating WT1 DNA fusion gene vaccination with intramuscular injection and electroporation for haematological mal…
-
CLINICAL_TRIALS trial_result · 2018-09-05Clinical Trial Update: Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia [Phase 2]
A phase 2 clinical trial evaluating the combination of bexarotene and GM-CSF in patients with myelodysplastic syndromes or acute myeloid leu…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer [Phase 2]
Phase 2 trial update on a combination chemotherapy, bone marrow transplant, and post-transplant cyclophosphamide regimen for hematologic can…
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI [Phase 1, Phase 2]
Phase 1/2 clinical trial update for Philadelphia chromosome–positive CML patients with suboptimal response or tolerance to Bcr-Abl TKIs.
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia [Phase 2]
Phase 2 clinical trial update for a vaccine therapy in Philadelphia chromosome-positive chronic myeloid leukemia (CML) completed; results po…
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: An Open-label Phase II Study of Lorvotuzumab Mertansine [Phase 2]
Open-label Phase II trial of Lorvotuzumab Mertansine (IMG_???), completed with results posted in 2018 for leukemia.
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant [Phase 2]
Phase 2 clinical trial update on CD34+ selection for partially matched family or matched unrelated adult donor transplants in leukemia and l…
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Cholecalciferol in Treating Patients With Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating cholecalciferol (vitamin D3) for treating patients with myelodysplastic syndromes, completed.